Copyright
©The Author(s) 2025.
World J Psychiatry. May 19, 2025; 15(5): 100731
Published online May 19, 2025. doi: 10.5498/wjp.v15.i5.100731
Published online May 19, 2025. doi: 10.5498/wjp.v15.i5.100731
Table 1 Comparisons of demographic characteristics in attention deficit and hyperactivity disorder children with or without speech and language therapy before propensity matching, n (%)
Variable | ADHD children | P value | |
Non-ST cohort (n = 9076) | ST cohort (n = 2911) | ||
Gender | 0.2531 | ||
Girls | 2031 (22.4) | 622 (21.4) | |
Boys | 7045 (77.6) | 2289 (78.6) | |
Age at ADHD diagnosis (mean ± SD) | 5.99 (1.47) | 4.92 (1.54) | < 0.0012 |
≥ 4 years | 1012 (11.2) | 809 (27.8) | < 0.0011 |
> 4 years | 8064 (88.8) | 2102 (72.2) | |
Urbanization | < 0.0011 | ||
1 (highest) | 3159 (34.8) | 881 (30.3) | |
2 | 2525 (27.8) | 753 (25.9) | |
3 | 1938 (21.4) | 570 (19.6) | |
4 | 1035 (11.4) | 313 (10.8) | |
5 (lowest) | 419 (4.6) | 394 (13.5) | |
Comorbidities | |||
Cerebral palsy | 121 (1.3) | 229 (7.9) | < 0.0011 |
Autism | 420 (4.6) | 712 (24.5) | < 0.0011 |
Hearing loss | 569 (6.3) | 648 (22.3) | < 0.0011 |
Delay development (including language or speech delay) | 2729 (30.1) | 2361 (81.1) | < 0.0011 |
Mental retardation | 1035 (11.4) | 1063 (36.5) | < 0.0011 |
Behavioral interventions | < 0.0011 | ||
No | 4951 (54.6) | 1153 (39.6) | |
Yes | 4125 (45.4) | 1758 (60.4) | |
ADHD medication used | < 0.0011 | ||
None | 4481 (49.4) | 1454 (49.9) | |
Methylphenidate HCL (Ritalin/Concerta) | 4574 (50.4) | 1450 (49.8) | |
Atomoxetine (Strattera) | 391 (4.3) | 184 (6.3) | |
Used 2 types | 370 (4.1) | 547 (4.6) |
- Citation: Tzang RF, Lin YW, Kao KL, Chang YC, Huang HC, Wu SY, Wu SI, Stewart R. Subsequent psychiatric disorders in attention deficit and hyperactivity children receiving speech therapy. World J Psychiatry 2025; 15(5): 100731
- URL: https://www.wjgnet.com/2220-3206/full/v15/i5/100731.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i5.100731